Founded in 2010 in North Carolina, NovaQuest Capital Management is a life science investment firm with over $2.5 billion across multiple asset classes, focusing on biopharmaceuticals and animal health. The firm, which started as a strategic investment arm within Quintiles Transnational and later became independent, provides structured finance investments for late-stage biopharmaceutical products and animal health companies, with special interest in pharmaceuticals, nutritional health, technology, diagnostics, and genetics.
Loading chart data...
(Latest available fund marks; returns metrics net of fees and expenses; fund size in billions)
| Fund | Vintage | Mark | Size | Called | IRR | TVPI | DPI | RVPI |
|---|---|---|---|---|---|---|---|---|
| NovaQuest Private Equity Fund I, L.P. | 2019 | Mar. '23 | $0.1 | 35.4% | ||||
| NovaQuest Private Equity Fund II, L.P. | 2021 | Mar. '23 | $0.3 | 10.4% |